Neurologic clinical trial - Ivy Brain Tumor Center: 2020-08

Neurologic

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

CONDITIONS: Glioblastoma, glioma, GBM - A Phase 0 Study of Infigratinib in Recurrent High-Grade Glioma Participants Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration With PK Triggered Expansion Cohort

Drug

Infigratinib

Phase

Phase 1

Condition

Glioblastoma glioma GBM